Evidence map›Paper›PMID 27611939›Full record

ArticlePloS one2016

Detection of African Swine Fever Virus Antibodies in Serum and Oral Fluid Specimens Using a Recombinant Protein 30 (p30) Dual Matrix Indirect ELISA.

Luis G Giménez-Lirola, Lina Mur, Belen Rivera, Mark Mogler, Yaxuan Sun, Sergio Lizano, Christa Goodell, D L Hank Harris, Raymond R R Rowland, Carmina Gallardo and 2 more

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 55 papers.

0numbers the graph read from it
0cells of the map it votes in
55citing papers in PubMed
10.1field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

55 citing papers in PubMed, 103 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Review
  15. Article
  16. Article
  17. Article
  18. Review
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 4 institutions in 2 countries.

Luis G Giménez-LirolaCollege of Veterinary Medicine, Iowa State University, Ames, Iowa, United States of America.
Lina MurVISAVET Center and Animal Health Department, University Complutense of Madrid, Spain.
Belen RiveraVISAVET Center and Animal Health Department, University Complutense of Madrid, Spain.
Mark MoglerHarrisvaccines, Inc, Ames, Iowa, United States of America.
Yaxuan SunCollege of Liberal Arts and Sciences, Iowa State University, Ames, Iowa, United States of America.
Sergio LizanoIDEXX Laboratories, Westbrook, Maine, United States of America.
Christa GoodellIDEXX Laboratories, Westbrook, Maine, United States of America.
D L Hank HarrisHarrisvaccines, Inc, Ames, Iowa, United States of America.
Raymond R R RowlandCollege of Veterinary Medicine, Kansas State University, Manhattan, Kansas, United States of America.
Carmina GallardoCISA-INIA, Madrid, Spain.
José Manuel Sánchez-VizcaínoVISAVET Center and Animal Health Department, University Complutense of Madrid, Spain.
Jeff ZimmermanCollege of Veterinary Medicine, Iowa State University, Ames, Iowa, United States of America.
Iowa State University · USIDEXX Laboratories (United States) · USIngenieria Y Economia Del Transporte · ESKansas State University · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

In the absence of effective vaccine(s), control of African swine fever caused by African swine fever virus (ASFV) must be based on early, efficient, cost-effective detection and strict control and elimination strategies. For this purpose, we developed an indirect ELISA capable of detecting ASFV antibodies in either serum or oral fluid specimens. The recombinant protein used in the ELISA was selected by comparing the early serum antibody response of ASFV-infected pigs (NHV-p68 isolate) to three major recombinant polypeptides (p30, p54, p72) using a multiplex fluorescent microbead-based immunoassay (FMIA). Non-hazardous (non-infectious) antibody-positive serum for use as plate positive controls and for the calculation of sample-to-positive (S:P) ratios was produced by inoculating pigs with a replicon particle (RP) vaccine expressing the ASFV p30 gene. The optimized ELISA detected anti-p30 antibodies in serum and/or oral fluid samples from pigs inoculated with ASFV under experimental conditions beginning 8 to 12 days post inoculation. Tests on serum (n = 200) and oral fluid (n = 200) field samples from an ASFV-free population demonstrated that the assay was highly diagnostically specific. The convenience and diagnostic utility of oral fluid sampling combined with the flexibility to test either serum or oral fluid on the same platform suggests that this assay will be highly useful under the conditions for which OIE recommends ASFV antibody surveillance, i.e., in ASFV-endemic areas and for the detection of infections with ASFV isolates of low virulence.

Indexed as

Enzyme-Linked Immunosorbent AssayAfrican Swine FeverAfrican Swine Fever VirusAnimalsAntibodies, ViralAntigens, ViralPhosphoproteinsReproducibility of ResultsSwineViral ProteinsAntibodies, ViralAntigens, ViralP30 protein, African Swine Fever VirusPhosphoproteinsViral Proteins

Identifiers

PMID27611939
PMCPMC5017782
OpenAlexW2515986932

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.